News
All the latest fundraises and exits from Asian-heritage founders in the UK.
Semarion Raises £2M to Fix the Cell Models That Drug Discovery Relies On
£2M
Arāya Ventures Secures £18.2 Million to Propel UK Startups with New Super Angel Fund
£18.2M
Oxford Cancer Analytics Raises $11M to Advance AI-Driven Blood Tests for Early Cancer Detection.
$11M
Sightline Climate Secures $5.5M to Power Climate Tech Market Intelligence
$5.5M
Cera Raises $150M Series C to Scale AI-Led Home Healthcare Across the UK
$150M
Calla Lily Clinical Care Raises £2.3M to Advance Vaginal Drug Delivery for Gynaecological Conditions
£2.3M
MindLabs Raises £2M to Make Mental Wellness Practical Through On-Demand Guided Sessions
£2M
New Wave Biotech raises over $1.2M for its its AI-driven bioprocess simulation software
$1.2M
Mitra Bio Raises £4.7M to Pioneer Non-Invasive Skin Epigenetics Testing for Longevity and Skincare
£4.7M
52 North Secures $6M Funding to Advance Oncology Point-of-Care Diagnostics
$6M
NovalGen Raises £1.8M to Engineer Bispecific Antibodies That Turn Tumours Against Themselves
£1.8M
52 North Health Raises £3.6M to Detect Deadly Sepsis in Cancer Patients Before It Becomes Fatal
£3.6M
Oxford Vacmedix Raises £3M to Make Vaccines More Powerful and Cheaper to Produce
£3M
Patchwork Health Acquires L2P to Streamline Healthcare Workforce Management
Acquired
InnotiveDx Raises £3.1M to Bring Fast, Accurate UTI Diagnosis to the Point of Care
£3.1M
Scalpel AI Raises £3.8M to Digitise Surgical Instrument Tracking With Computer Vision
£3.8M
Psyrin raises $1 million to advance its pioneering approach to mental health assessment using voice biomarkers
$1M
Abselion Raises £6.6M Series A to Bring At-Line Protein Quantification to the Biopharmaceutical Industry
£6.6M
Verdiva Bio Launches with $411M Series A to Challenge the Obesity Drug Market
$411M
MV.Health Raises £2.9M to Develop Medical Devices for Underserved Sexual Health Conditions
£2.9M
MintNeuro Raises £2M to Build the Next Generation of Neural Implant Hardware
£2M
Nuclera Raises £57M to Put Protein Synthesis on Every Researcher’s Desk
£57M
Purespring Therapeutics Raises £80M to Advance Gene Therapy for Kidney Disease
£80M
Constructive Bio Raises £43M to Commercialise Expanded Genetic Code Technology
£43M
GPDQ Raises £1.2M to Bring GP Home Visits Back With a Digital-First Booking Platform
£1.2M